Search by Drug Name or NDC
NDC 00132-0201-40 Fleet 7; 19 g/230mL; g/230mL Details
Fleet 7; 19 g/230mL; g/230mL
Fleet is a RECTAL ENEMA in the HUMAN OTC DRUG category. It is labeled and distributed by C.B. Fleet Company, Inc.. The primary component is SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC.
Product Information
NDC | 00132-0201 |
---|---|
Product ID | 0132-0201_b574e93a-5c0b-4eaa-b8ce-2e5ffc539afe |
Associated GPIs | 46109902105100 |
GCN Sequence Number | 003029 |
GCN Sequence Number Description | sodium phosphate,mono-dibasic ENEMA 19G-7G/118 RECTAL |
HIC3 | Q3S |
HIC3 Description | LAXATIVES, LOCAL/RECTAL |
GCN | 66559 |
HICL Sequence Number | 001330 |
HICL Sequence Number Description | SODIUM PHOSPHATE,MONOBASIC/SODIUM PHOSPHATE,DIBASIC |
Brand/Generic | Brand |
Proprietary Name | Fleet |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | sodium phosphate, dibasic and sodium phosphate, monobasic |
Product Type | HUMAN OTC DRUG |
Dosage Form | ENEMA |
Route | RECTAL |
Active Ingredient Strength | 7; 19 |
Active Ingredient Units | g/230mL; g/230mL |
Substance Name | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC |
Labeler Name | C.B. Fleet Company, Inc. |
Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 00132-0201-40 (00132020140)
NDC Package Code | 0132-0201-40 |
---|---|
Billing NDC | 00132020140 |
Package | 133 mL in 1 BOTTLE, WITH APPLICATOR (0132-0201-40) |
Marketing Start Date | 2017-05-15 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.00779 |
Pricing Unit | ML |
Effective Date | 2023-09-20 |
NDC Description | FLEET ENEMA |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 4, 5 |
Classification for Rate Setting | B |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL db7520d8-9364-4d7a-ba81-79a2fc2fa40e Details
Active Ingredient (in each 197-mL delivered dose)
Warnings
Ask a doctor before using this product if you
Stop use and ask a doctor if you have
Keep out of reach of children
Directions
Other information
- each 197-mL delivered dose contains: sodium 4.4 g
- additional liquids by mouth are recommended while taking this product
- this product generally produces a bowel movement in 1-5 minutes
- for complete professional use warnings and precautions, consult Reference Safety Information on our website
INGREDIENTS AND APPEARANCE
FLEET
sodium phosphate, dibasic and sodium phosphate, monobasic enema |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
Labeler - C.B. Fleet Company, Inc. (003119054) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
C.B. Fleet Company, Inc. | 003119054 | manufacture(0132-0201) |
Revised: 8/2017
Document Id: b574e93a-5c0b-4eaa-b8ce-2e5ffc539afe
Set id: db7520d8-9364-4d7a-ba81-79a2fc2fa40e
Version: 9
Effective Time: 20170822